The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

Q. Is there any cure for psoriasis? A. There’s no cure for psoriasis yet, but there are many ways to get relief from the symptoms of this troublesome disease. Psoriasis is one of the most ...

ABBV stock, with 24% returns since the beginning of 2024, has marginally underperformed the S&P 500 index, up 27%. An ...

Humira revenues were $8.99bn ... total revenues - protecting its pre-eminent position in these markets - Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis for Skyrizi ...

Total Net Revenues: $56.3 billion, exceeding initial guidance by more than $2 billion. Ex-HUMIRA Platform Sales Growth: More than 18% for the full year, 22% in the fourth quarter. SKYRIZI and ...

If you have psoriasis, you might take medication and keep close tabs on the weather, your stress level, and other triggers. Should you also watch what's on your plate? A healthy diet -- lots of ...

Psoriasis symptoms can worsen in the fall and winter months for some people. For some people with psoriasis, fall and winter bring shorter days, colder weather, and worsening psoriasis symptoms ...

Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

Two years after AbbVie’s loss of market exclusivity for Humira, those “How it Started ... of the total prescription share of the biologics psoriasis market, he said. Of the $4 billion ...